Publications
74
Citations
906
Est. group size
~6
Recurring co-author estimate
Active years
19
Publishing since 2008
Pankita H. Pandya studies cancer biology and treatment, with a strong focus on bone and soft-tissue tumors such as osteosarcoma, rhabdomyosarcoma, and glioblastoma. The work explores how to overcome drug resistance by targeting specific molecular pathways (for example, proteins controlling cell division and DNA repair), and also includes applying deep learning to analyze pathology images for cancer diagnosis.
Publication activity has fluctuated year to year but remained active overall, averaging about 7 papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer
Cancers · 2026
- Osteosarcoma chemosensitivity signatures from BETi with holographic dynamic-contrast OCT
2025
- Therapeutic Targeting of BET Proteins in Sarcoma
Molecular Cancer Therapeutics · 2025
- 54P A large-scale multi-site validation of a deep learning approach for determining ER, PR, and HER2 status from H&E-stained breast cancer slides
ESMO Open · 2025
- 91P Accelerating breast cancer diagnosis with a digital assay: Real-world evidence from a retrospective validation study
ESMO Open · 2025
- 121P Deep learning can predict MSI/MMR status from primary and metastatic colorectal tissue slides
Annals of Oncology · 2025
- 883eP AI-based multimodal prediction of MSI/MMR status in colorectal cancer from H&E-stained slides and clinicopathological data
Annals of Oncology · 2025
- Abstract 5719: Targeting CDK4/6 and BET proteins for the treatment of RB+ and RB- osteosarcoma
Cancer Research · 2024
- Enhancing anti-tumor potential: low-intensity vibration suppresses osteosarcoma progression and augments MSCs' tumor-suppressive abilities
Theranostics · 2024
- EXTH-43. TARGETING THE DNA DAMAGE RESPONSE THROUGH COMBINATION MDM2 AND AKT INHIBITOR THERAPY IMPROVES TEMOZOLOMIDE EFFECTIVENESS IN CHEMO-RESISTANT GLIOBLASTOMA
Neuro-Oncology · 2023
- Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining
Frontiers in Oncology · 2023
- Anticancer peptides from induced tumor-suppressing cells for inhibiting osteosarcoma cells.
PubMed · 2023
- 1226P Multi-site validation of a deep learning solution for HER2 profiling of breast cancer from H&E-stained pathology slides
Annals of Oncology · 2023
- Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins
eLife · 2023
- Author response: Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins
2023
- Cancer Research×21
- Figshare×5
- Cancers×4
- Annals of Oncology×3
- PMC×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile